 |
 |
 |
 |
|
| |
 |
| e-Learning program of Medical care for Hibakusha |
|
|
| Radiation Safety
and Risk Management |
|
|
|
Discussion points on radiation
safety, and scope of the University of Tokyo Global COE program |
|
| |
 |
|
|
| |
| Speaker : |
Takeshi Iimoto , Tokyo university, Tokyo, Japan |
|
| |
[ 29min 09sec ] |
|
|
|
|
Framework of radiation safety
management in Japan: laws, administrative agencies, and supporting associations |
|
| |
 |
|
|
| |
| Speaker : |
Naoki Matsuda, Nagasaki University, Nagasaki, Japan |
|
| |
[ 31min 03sec ] |
|
|
|
|
Background radiation dose to
the population around Kudankulam nuclear power plant ( in preparation
) |
|
| |
 |
|
|
| |
| Speaker : |
Subramaniyan Selvasekarapandian, Bharathiar University, Coimbatore,
India |
|
| |
[ 30min 07sec ] |
|
|
|
|
|
|
|
Current risk estimate of radiation-related
cancer and our insight into the future |
|
| |
 |
|
|
| |
| Speaker : |
Michiaki Kai, Oita University of Nursing and Health Sciences, Oita,
Japan |
|
| |
[ 23min 58sec ] |
|
|
|
|
Significance of oncogene amplifications
in breast cancer in atomic bomb survivors: associations with radiation exposure
and histological grade |
|
| |
 |
|
|
| |
| Speaker : |
Shiro Miura, Nagasaki University, Nagasaki, Japan |
|
| |
[ 22min 23sec ] |
|
|
|
|
Paracrine interactions between
normal, but not cancer epithelial and normal mesenchymal cells attenuate radiation-induced
DNA damage |
|
| |
 |
|
|
| |
| Speaker : |
Vladimir Saenko, Nagasaki University, Nagasaki, Japan |
|
| |
[ 27min 13sec ] |
|
|
|
|
Age and prognosis- do adjuvant
therapies influence the real prognosis? |
|
| |
 |
|
|
| |
| Speaker : |
Robert C. Leonard, Imperial College School of Medicine, London,
UK |
|
| |
[ 28min 11sec ] |
|
|
| Radiation Emergency
Medicine |
|
|
|
Network system for radiation
emergency medicine in Japan and the role of Hiroshima University |
|
| |
 |
|
|
| |
| Speaker : |
Kenji Kamiya, Hiroshima University, Hiroshima, Japan |
|
| |
[ 29min 34sec ] |
|
|
|
|
International cooperation in
radiation emergency medical preparedness: medical network in Asia |
|
| |
 |
|
|
| |
| Speaker : |
Makoto Akashi, National Institute of Radiological Sciences, Chiba,
Japan |
|
| |
[ 23min 11sec ] |
|
|
|
|
|
Update from the Chernobyl Tissue
Bank: effect of latency on different types of thyroid cancer post Chernobyl |
|
| |
 |
|
|
| |
| Speaker : |
Geraldine A. Thomas, Hammersmith Hospital, London, UK |
|
| |
[ 18min 06sec ] |
|
|
|
|
Mortality of the Chernobyl
emergency workers: analysis of dose response (cohort studies, 1992-2006) |
|
| |
 |
|
|
| |
| Speaker : |
Victor Ivanov, Medical Radiological Research Center of Russian Academy
of Medical Sciences, Obninsk, Russia |
|
| |
[ 26min 37sec ] |
|
|
|
|
Twenty years after Chernobyl:
implications for radiation health risk control |
|
| |
 |
|
|
| |
| Speaker : |
Yoshisada Shibata, Nagasaki University, Nagasaki, Japan |
|
| |
[ 28min 50sec ] |
|
|
|
|
Health status in children exposed
to the Chernobyl accident in utero: observations in 1989-2003 and their implications
for prioritizing prophylactic programs |
|
| |
 |
|
|
| |
| Speaker : |
Nataliya Korol, Research Center for Radiation Medicine of AMSU,
Kiev, Ukraine |
|
| |
[ 13min 25sec ] |
|
|
|
|
Thyroid cancer in Ukraine after
the Chernobyl accident: incidence, pathology, treatment, and molecular biology |
|
| |
 |
|
|
| |
| Speaker : |
Mykola Tronko, Institute of Endocrinology and Metabolism of AMSU,
Kiev, Ukraine |
|
| |
[ 22min 32sec ] |
|
|
|
|
Current trends in incidence
and mortality from thyroid carcinomas in Belarus |
|
| |
 |
|
|
| |
| Speaker : |
Pavel I. Bespalchuk, Belarussian State Medical University, Minsk,
Belarus |
|
| |
[ 15min 16sec ] |
|
|
| Semipalatinsk Nuclear
Test |
|
|
|
Fallout exposure of the population
and thyroid nodular diseases |
|
| |
 |
|
|
| |
| Speaker : |
Zhaxybay Zhumadilov, Semipalatinsk State Medical Academy, Semipalatinsk,
Kazakhstan |
|
| |
[ 17min 52sec ] |
|
|
|
|
The status of health of the
population of Semipalatinsk region and the scientifically-proved measures of
its improvement |
|
| |
 |
|
|
| |
| Speaker : |
Tolebay K. Rakhypbekov, Semipalatinsk State Medical Academy, Semipalatinsk,
Kazakhstan |
|
| |
[ 07min 12sec ] |
|
|
|
|
Atomic bomb disease and public
health development |
|
| |
 |
|
|
| |
| Speaker : |
Serik Meirmanov, Nagasaki University, Nagasaki, Japan |
|
| |
[ 13min 11sec ] |
|
|
|
|
|
|
|
|
| |
|
|
|
